HomeHRTIS • HEL
add
Herantis Pharma Oyj
Previous close
€1.41
Day range
€1.35 - €1.43
Year range
€1.18 - €1.88
Market cap
33.37M EUR
Avg Volume
13.75K
P/E ratio
-
Dividend yield
-
Primary exchange
HEL
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.14M | 188.61% |
Net income | -1.13M | -208.55% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.13M | -67.10% |
Total assets | 2.57M | -61.88% |
Total liabilities | 2.81M | 39.37% |
Total equity | -242.91K | — |
Shares outstanding | 20.16M | — |
Price to book | -140.50 | — |
Return on assets | -110.37% | — |
Return on capital | 1,679.93% | — |
Cash Flow
Net change in cash
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -1.13M | -208.55% |
Cash from operations | -1.76M | -20.25% |
Cash from investing | -42.00 | -202.44% |
Cash from financing | 1.08M | -52.05% |
Net change in cash | -677.26K | -185.88% |
Free cash flow | -718.31K | -189.71% |
About
Founded
2008
Website
Employees
11
